Supply Chain ManagementEmerging Markets practice |
Deloitte understands the particular constraints that are placed on the pharmaceutical and health product supply chains of developing countries. The lack of reliable data and mechanisms to properly forecast demand contributes to stock outs and expired inventory, while parallel systems and workforce capacity often inhibit efficient supply chain execution.
Through Deloitte’s extensive healthcare, supply chain, and emerging markets capabilities, we offer an insightful and innovative approach, tailoring our methods, tools, and leading practices to the specific needs and context of each country we support. We apply our end-to-end knowledge and skills in supply chain planning, sourcing and procurement, warehousing and distribution, and secure supply chain management (e.g., theft, fraudulent orders, counterfeit commodities) to develop and implement holistic and sustainable solutions that strengthen health systems across the entire private/public supply chain.
Featured projects
 |
Supply chain management capability assessment of HIV/AIDS service providers in Uganda Deloitte assisted the President’s Emergency Plan for AIDS Relief (PEPFAR) in Uganda to assess supply chain management capacities of indigenous organizations. |
 |
Medicinal procurement capacity building in Mozambique Deloitte is supporting the Ministry of Health’s Planning Department in Mozambique to strengthen supply chain management capacity at the central level. |
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity. Please see www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its member firms. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.
Zero to hero: Helping a pharma company start up global operations to deliver a potentially life-saving antiviral
(112.17 KB)
